Antimyelin CD4+ T cells in MS have been widely studied because of their role in regulating cell-mediated inflammation, their ability in inducing EAE, and the identification of HLA-DRB1*15 allele as the most significant genetic risk factor associated with MS [33]. Here, HLA-DRB1 is linked to myeloid sarcoma.